Main topics
- Rare/genetic diseases
- Experimental models
- Therapies for genetic diseases
Keynote & Featured lectures
-
TBA
Invited speakers
- TBA
- TBA
- TBA
- TBA
Dear Colleagues,
It is my great pleasure to invite you to the eighth CCP Phenogenomics Conference.
The scientific committee has selected the topic of rare diseases: experimental models & delivery of therapies as the main thematic focus of this year Conference.
We believe that the Conference will provide again an excellent opportunity to support networking and interactions among the researchers, CCP staff, users and experts from the commercial sector.
We are looking forward to meeting you either in Prague or virtually in September 2026.
Yours sincerely,
Radislav Sedlacek
Director of the Czech Centre for Phenogenomics
Institute of Molecular Genetics of the Czech Academy of Sciences
Czech Centre for Phenogenomics (CCP)
The Czech Centre for Phenogenomics marks its tenth anniversary as a leading national and European infrastructure for disease modelling and phenotyping, having grown from a small transgenic unit into one of Europe’s most comprehensive centres.
With over 140 experts and an integrated pipeline spanning genome editing, high-throughput phenotyping, and preclinical testing, CCP serves as a “one-stop shop” for academic and industrial users and plays a key role in international initiatives such as INFRAFRONTIER and the International Mouse Phenotyping Consortium. By combining state-of-the-art in vivo technologies with forward-looking investments in rare disease research, gene therapy, advanced in vitro models, and AI-driven phenotyping, CCP stands as a mature, internationally recognised hub committed to innovation and scientific excellence for the benefit of society.
The conference is organized within the scope of the research programme “Towards Precision Medicine and Gene Therapy” of the Strategy AV21 supported by the Czech Academy of Sciences.
The conference covers topics related to the research focus of the National centre for new methods of diagnosis, monitoring, treatment and prevention of genetic diseases This project (ID: TN02000132, 2023 – 2026) is co-funded with state aid by the Technology Agency of the Czech Republic in the framework of the Programme National Centres of Competence.